Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05883163 · ClinicalTrials.gov registry record · NA
STIMIT Activator 1 IDE Study
A NA study of Diaphragm Issues, sponsored by Stimit.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT05883163: Recruiting NA study of Diaphragm Issues, sponsored by Stimit.
NCT05883163 is a NA study of Diaphragm Issues that is actively recruiting participants, run by Stimit. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05883163, a NA study of Diaphragm Issues, is actively recruiting participants, sponsored by Stimit.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
The study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 7 days and are predicted to require additional minimum 48 hours of mechanical ventilation or longer.
Primary Outcome
The intra-individual change in diaphragm thickness will be measured daily via ultrasound and compared between intervention and control groups.
Conditions Studied
Interventions
- DEVICE Stimit Activator 1
Study Locations (4)
Connecticut
- Yale New Haven Hospital - New Haven
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Virginia
- University of Virginia Medical Center - Charlottesville
Other
- St Michael's Hospital Unity Health Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05883163 shows while recruiting
NCT05883163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Diaphragm Issues appearing as the primary indexed condition, and to 1 intervention - of which Stimit Activator 1 is the first listed.
NCT05883163 reports a single indexed study location in Connecticut, Massachusetts, Virginia.
Frequently Asked Questions
What is clinical trial NCT05883163 about?
NCT05883163 is a clinical study titled "STIMIT Activator 1 IDE Study". The study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 7 days and are predicted to require additional m...
What is the current status of trial NCT05883163?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-01-24. Estimated completion is 2026-07.
What conditions does trial NCT05883163 study?
This clinical trial studies the following conditions: Diaphragm Issues.
What interventions are being tested in trial NCT05883163?
The interventions under investigation include: Stimit Activator 1 (DEVICE).
Who is sponsoring clinical trial NCT05883163?
This trial is sponsored by Stimit, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05883163 being conducted?
This trial has 4 study locations across Connecticut, Massachusetts, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diaphragm Issues
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05883163's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI